Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene - PubMed (original) (raw)
. 1997 Apr 11;272(15):9809-17.
doi: 10.1074/jbc.272.15.9809.
Affiliations
- PMID: 9092515
- DOI: 10.1074/jbc.272.15.9809
Free article
Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene
M M Nagiec et al. J Biol Chem. 1997.
Free article
Abstract
We have identified a Saccharomyces cerevisiae gene necessary for the step in sphingolipid synthesis in which inositol phosphate is added to ceramide to form inositol-P-ceramide, a reaction catalyzed by phosphatidylinositol:ceramide phosphoinositol transferase (IPC synthase). This step should be an effective target for antifungal drugs. A key element in our experiments was the development of a procedure for isolating mutants defective in steps in sphingolipid synthesis downstream from the first step including a mutant defective in IPC synthase. An IPC synthase defect is supported by data showing a failure of the mutant strain to incorporate radioactive inositol or N-acetylsphinganine into sphingolipids and, by using an improved assay, a demonstration that the mutant strain lacks enzyme activity. Furthermore, the mutant accumulates ceramide when fed exogenous phytosphingosine as expected for a strain lacking IPC synthase activity. Ceramide accumulation is accompanied by cell death, suggesting the presence of a ceramide-activated death response in yeast. A gene, AUR1 (YKL004w), that complements the IPC synthase defect and restores enzyme activity and sphingolipid synthesis was isolated. Mutations in AUR1 had been shown previously to give resistance to the antifungal drug aureobasidin A, leading us to predict that the drug should inhibit IPC synthase activity. Our data show that the drug is a potent inhibitor of IPC synthase with an IC50 of about 0.2 nM. Fungal pathogens are an increasing threat to human health. Now that IPC synthase has been shown to be the target for aureobasidin A, it should be possible to develop high throughput screens to identify new inhibitors of IPC synthase to combat fungal diseases.
Similar articles
- Synthesis of mannose-(inositol-P)2-ceramide, the major sphingolipid in Saccharomyces cerevisiae, requires the IPT1 (YDR072c) gene.
Dickson RC, Nagiec EE, Wells GB, Nagiec MM, Lester RL. Dickson RC, et al. J Biol Chem. 1997 Nov 21;272(47):29620-5. doi: 10.1074/jbc.272.47.29620. J Biol Chem. 1997. PMID: 9368028 - Inhibition of yeast inositol phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay.
Zhong W, Murphy DJ, Georgopapadakou NH. Zhong W, et al. FEBS Lett. 1999 Dec 17;463(3):241-4. doi: 10.1016/s0014-5793(99)01633-6. FEBS Lett. 1999. PMID: 10606729 - An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity.
Kuroda M, Hashida-Okado T, Yasumoto R, Gomi K, Kato I, Takesako K. Kuroda M, et al. Mol Gen Genet. 1999 Mar;261(2):290-6. doi: 10.1007/s004380050969. Mol Gen Genet. 1999. PMID: 10102364 - IPC synthase as a useful target for antifungal drugs.
Sugimoto Y, Sakoh H, Yamada K. Sugimoto Y, et al. Curr Drug Targets Infect Disord. 2004 Dec;4(4):311-22. doi: 10.2174/1568005043340597. Curr Drug Targets Infect Disord. 2004. PMID: 15578972 Review. - Yeast sphingolipids.
Dickson RC, Lester RL. Dickson RC, et al. Biochim Biophys Acta. 1999 Jan 6;1426(2):347-57. doi: 10.1016/s0304-4165(98)00135-4. Biochim Biophys Acta. 1999. PMID: 9878820 Review.
Cited by
- Complex sphingolipid profiling and identification of an inositol-phosphorylceramide synthase in Dictyostelium discoideum.
Listian SA, Mazur AC, Kol M, Ufelmann E, Eising S, Fröhlich F, Walter S, Holthuis JCM, Barisch C. Listian SA, et al. iScience. 2024 Jul 30;27(9):110609. doi: 10.1016/j.isci.2024.110609. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286488 Free PMC article. - Evaluation of the Leishmania Inositol Phosphorylceramide Synthase as a Drug Target Using a Chemical and Genetic Approach.
Alpizar-Sosa EA, Zimbres FM, Mantilla BS, Dickie EA, Wei W, Burle-Caldas GA, Filipe LNS, Van Bocxlaer K, Price HP, Ibarra-Meneses AV, Beaudry F, Fernandez-Prada C, Whitfield PD, Barrett MP, Denny PW. Alpizar-Sosa EA, et al. ACS Infect Dis. 2024 Aug 9;10(8):2913-2928. doi: 10.1021/acsinfecdis.4c00284. Epub 2024 Jul 18. ACS Infect Dis. 2024. PMID: 39023360 Free PMC article. - Innovations in Antifungal Drug Discovery among Cell Envelope Synthesis Enzymes through Structural Insights.
Zhou Y, Reynolds TB. Zhou Y, et al. J Fungi (Basel). 2024 Feb 22;10(3):171. doi: 10.3390/jof10030171. J Fungi (Basel). 2024. PMID: 38535180 Free PMC article. Review. - Hyperpolarisation of Mitochondrial Membranes Is a Critical Component of the Antifungal Mechanism of the Plant Defensin, Ppdef1.
Parisi K, McKenna JA, Lowe R, Harris KS, Shafee T, Guarino R, Lee E, van der Weerden NL, Bleackley MR, Anderson MA. Parisi K, et al. J Fungi (Basel). 2024 Jan 7;10(1):54. doi: 10.3390/jof10010054. J Fungi (Basel). 2024. PMID: 38248963 Free PMC article. - Calcineurin-dependent contributions to fitness in the opportunistic pathogen Candida glabrata.
Pavesic MW, Gale AN, Nickels TJ, Harrington AA, Bussey M, Cunningham KW. Pavesic MW, et al. mSphere. 2024 Jan 30;9(1):e0055423. doi: 10.1128/msphere.00554-23. Epub 2024 Jan 3. mSphere. 2024. PMID: 38171022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases